IL111036A - Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL111036A
IL111036A IL11103694A IL11103694A IL111036A IL 111036 A IL111036 A IL 111036A IL 11103694 A IL11103694 A IL 11103694A IL 11103694 A IL11103694 A IL 11103694A IL 111036 A IL111036 A IL 111036A
Authority
IL
Israel
Prior art keywords
beta
preparation
same
pharmaceutical compositions
alanine derivatives
Prior art date
Application number
IL11103694A
Other languages
English (en)
Other versions
IL111036A0 (en
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939319561A external-priority patent/GB9319561D0/en
Priority claimed from GB9413936A external-priority patent/GB9413936D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Priority to IL12682594A priority Critical patent/IL126825A/xx
Publication of IL111036A0 publication Critical patent/IL111036A0/xx
Priority to IL12682598A priority patent/IL126825A0/xx
Publication of IL111036A publication Critical patent/IL111036A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11103694A 1993-09-22 1994-09-22 Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same IL111036A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL12682594A IL126825A (en) 1993-09-22 1994-09-22 beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them
IL12682598A IL126825A0 (en) 1993-09-22 1998-10-30 Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939319561A GB9319561D0 (en) 1993-09-22 1993-09-22 Beta-alanine derivative and a process for preparation thereof
GB9413936A GB9413936D0 (en) 1994-07-11 1994-07-11 Beta-Alanine derivative and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
IL111036A0 IL111036A0 (en) 1994-11-28
IL111036A true IL111036A (en) 1999-07-14

Family

ID=26303555

Family Applications (3)

Application Number Title Priority Date Filing Date
IL12682594A IL126825A (en) 1993-09-22 1994-09-22 beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them
IL11103694A IL111036A (en) 1993-09-22 1994-09-22 Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL12682598A IL126825A0 (en) 1993-09-22 1998-10-30 Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL12682594A IL126825A (en) 1993-09-22 1994-09-22 beta-Alanine drivatives processes for their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL12682598A IL126825A0 (en) 1993-09-22 1998-10-30 Beta-alanine derivatives processes for their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US6380215B1 (xx)
EP (2) EP0669912B1 (xx)
CN (1) CN1041919C (xx)
AT (1) ATE210118T1 (xx)
AU (1) AU684547B2 (xx)
CA (1) CA2157792C (xx)
DE (1) DE69429328T2 (xx)
DK (1) DK0669912T3 (xx)
ES (1) ES2164109T3 (xx)
HK (1) HK1004985A1 (xx)
HU (1) HUT73174A (xx)
IL (3) IL126825A (xx)
PT (1) PT669912E (xx)
RU (1) RU2161155C2 (xx)
TW (1) TW401414B (xx)
WO (1) WO1995008536A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010051730A1 (en) * 1993-09-22 2001-12-13 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivative and a process for the preparation thereof
IL117495A (en) * 1995-03-17 2002-05-23 Fujisawa Pharmaceutical Co History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them
KR19990087694A (ko) * 1996-03-13 1999-12-27 후지야마 아키라 피브리노겐 수용체 길항제로서의 N-[(R)-1-{3-(4-피페리딜)프로피오닐-3-피페리딜카보닐]-2(S)-아세틸아미노-β-알라닌
ATE421952T1 (de) * 1996-05-01 2009-02-15 Ortho Mcneil Pharm Inc Carboxamidderivate von pyrrolidin, piperidin und hexahydropiperizin für behandlung von thrombosen
EP1184374B1 (en) * 1996-05-01 2009-01-28 Ortho-McNeil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
EP1000030A1 (en) * 1997-07-14 2000-05-17 Phytera Symbion ApS Piperidine oligomers and combinatorial libraries thereof
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
WO1999025685A1 (en) * 1997-11-18 1999-05-27 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
AU769718B2 (en) * 1998-10-12 2004-02-05 Fujisawa Pharmaceutical Co., Ltd. New processes for producing beta-alanine derivative
AUPP646598A0 (en) * 1998-10-12 1998-11-05 Fujisawa Pharmaceutical Co., Ltd. New processes for producing alpha-alanine derivative
SK13562001A3 (sk) * 1999-03-22 2002-08-06 Ortho-Mcneil Pharmaceutical, Inc. Spôsob prípravy [S-(R*,S*)]-beta-[[[1-[1-oxo-3-(4-piperidinyl)- propyl]-3-piperidinyl]karbonyl]amino]-3-pyridínpropánovej kyseliny a derivátov
DE60021521T4 (de) 1999-09-29 2006-09-21 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamide zur behandlung von integrin vermittelten störungen
AUPQ570100A0 (en) 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
JP2004529918A (ja) 2001-04-09 2004-09-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物
JP4910695B2 (ja) 2004-02-25 2012-04-04 アステラス製薬株式会社 血栓造影剤
NZ620635A (en) 2011-08-17 2015-09-25 Piramal Imaging Sa Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
EP2956461A1 (en) 2013-02-12 2015-12-23 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
KR102548998B1 (ko) 2020-03-31 2023-06-29 재단법인 아산사회복지재단 혈전영상을 위한 방사성의약품 및 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03257624A (ja) * 1990-03-08 1991-11-18 Fujitsu Ltd 画面言語方式
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
CA2054627A1 (en) * 1991-02-13 1992-08-14 Yea-Shun Cheng Polypeptide skeletal muscle relaxants
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds

Also Published As

Publication number Publication date
EP0669912A1 (en) 1995-09-06
DE69429328D1 (de) 2002-01-17
CA2157792A1 (en) 1995-03-30
CA2157792C (en) 2005-05-24
CN1041919C (zh) 1999-02-03
HU9501845D0 (en) 1995-08-28
TW401414B (en) 2000-08-11
ES2164109T3 (es) 2002-02-16
AU684547B2 (en) 1997-12-18
IL126825A (en) 1999-09-22
EP0669912B1 (en) 2001-12-05
AU7665794A (en) 1995-04-10
IL111036A0 (en) 1994-11-28
HUT73174A (en) 1996-06-28
PT669912E (pt) 2002-03-28
WO1995008536A1 (en) 1995-03-30
CN1116847A (zh) 1996-02-14
RU2161155C2 (ru) 2000-12-27
DK0669912T3 (da) 2002-03-04
US6380215B1 (en) 2002-04-30
IL126825A0 (en) 1999-08-17
RU95112456A (ru) 1997-04-20
EP1106606A3 (en) 2003-10-22
EP1106606A2 (en) 2001-06-13
ATE210118T1 (de) 2001-12-15
HK1004985A1 (en) 1998-12-18
DE69429328T2 (de) 2002-06-13

Similar Documents

Publication Publication Date Title
IL111036A (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HU9303145D0 (en) Process for producing of fibrinogen receptor antagonist compounds and pharmaceutical compositions containing them as medical agent
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
EA200400432A1 (ru) Производные мочевины
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
IL148384A0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
MY123354A (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
HK1094191A1 (en) Phenyl-carboxamide compounds useful for treating pain
ATE321543T1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.
ZA891769B (en) Heterocyclic compounds
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
ATE441653T1 (de) Phosphorenthaltende verbindugnen mit antithrombitische wirkung
EP1232748A4 (en) SUBSTITUTED NITROBENZENE-LIKE DERIVATIVE PRODUCT AS A MEDICINAL PRODUCT OR OTHER EFFICIENT PRODUCTS
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
EP0823254A4 (en) NEW USE OF PYRAZOLOPYRIDINE COMPOUNDS
MY135855A (en) "pyrrolopyrimidinone derivatives, process of preparation and use"
DE69622868D1 (de) Inhibitoren der blutplättchen-aggregation, die c-terminale aminosäurereste mit aminergen seitenketten enthalten

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees